King's College London
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, King's College London sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
King's College London: 5 sponsored US clinical trials, 1 recruiting.
King's College London sponsors 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. The most-studied condition in this pipeline is Juvenile Myoclonic Epilepsy, with 1 trials.
Upper-quartile sponsor footprint
King's College London sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
Biology of Juvenile Myoclonic Epilepsy
NCT03400371
COVID-19 Symptom Tracker
NCT04331509
Rolandic Epilepsy Genomewide Association International Study
NCT03547050
Hypoglycaemia Awareness Restoration Programme
NCT02940873
Genetics of Rolandic Epilepsy
NCT00282854
Therapeutic Areas
What is open in the King's College London pipeline
1 recruiting of 5 indexed (20% open); 3 completed (60%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Juvenile Myoclonic Epilepsy (1 trial), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
King's College London: open-pipeline peers nationwide
Peers matched on 5 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
King's College London sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
- Amazentis · 20% recruiting · 5 trials
Related
What to do with this King's College London page
5 registered trials is a research-attention snapshot, not an endorsement of King's College London or any single study.
- 1 of King's College London's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Juvenile Myoclonic Epilepsy is the condition King's College London studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Juvenile Myoclonic Epilepsy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
King's College London pipeline card: 5 registered trials from official public datasets.Report a data error.